Journal Report

European respiratory journal : official journal of the Europe

Download PDF
Journal Information
Journal Title
European respiratory journal : official journal of the Europe
Publisher
ISSN
0903-1936
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
A frequent ancestral intronic founder variant in <i>DNAI1</i> causes primary ciliary dyskinesia
Niki T. Loges, Ina Baumann, Dörthe Thüß et al.
2026-10-29 Pages 2601575
Don't discard the supernatant: pleural fluid cfDNA for molecular profiling in lung cancer
José M. Porcel
2026-10-29 Pages 2601861
Fibrosis extent on HRCT: the principal structural imaging biomarker for antifibrotic trials
Simon L. F. Walsh, Toby M. Maher, Martin Kolb et al.
2026-10-29 Pages 2601645
Muco-obstructive lung disease exhibits distinct hypoxic and inflammatory airway epithelial gene pathways
Yu Mikami, Ella Burns, Hong Dang et al.
2026-10-29 Pages 2502798
Fibrotic Morphology and Survival in Interstitial Pneumonia with Autoimmune Features
Adelle S. Jee, Janelle Vu Pugashetti, Leda Yazbeck et al.
2026-10-23 Pages 2600978
Persistent global inequalities in therapeutic respiratory devices
Ramon Farré
2026-10-23 Pages 2601998
Circulating Activin A, FSTL3 and BMP9 in asymptomatic <i>BMPR2</i> pathogenic-variant carriers
David Montani, Ly Tu, Athénaïs Boucly et al.
2026-10-23 Pages 2502183
Distinct clinical presentation and prognosis of chronic beryllium disease <i>versus</i> pulmonary sarcoidosis: a national multicentre case–control study
Cécile Rotenberg, Stéphane Tran Ba, Sylvain Marchand-Adam et al.
2026-10-23 Pages 2601348
Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants
Ritah Nabunje, Beatriz Guillen-Guio, Tamara Hernandez-Beeftink et al.
2026-10-23 Pages 2600962
Comparative Safety and Efficacy of Apixaban and Rivaroxaban During Extended Anticoagulation for Venous Thromboembolism: A Non-randomised Post Hoc Comparison Within the RENOVE Trial
Philippe Girard, Emilie Presles, Olivier Sanchez et al.
2026-10-23 Pages 2600968
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 30, 2026 03:55